Traws Pharma (TRAW) Earnings Date & Reports

Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

TRAW is expected to report earnings to rise 46.34% to -120 cents per share on August 06

Traws Pharma TRAW Stock Earnings Reports

Q2'26

Est.

$-1.20

Q4'25

Beat

by $8.74

Q3'25

Beat

by $8.82

Q2'25

Beat

by $8.59

Q1'25

Beat

by $2.36

The last earnings report on April 15 showed earnings per share of -81 cents, beating the estimate of -956 cents. With 857.89K shares outstanding, the current market capitalization sits at 12.71M.

View a ticker or compare two or three

Compare

TRAW

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for TRAW